Details for New Drug Application (NDA): 203557
✉ Email this page to a colleague
The generic ingredient in PIPERACILLIN AND TAZOBACTAM is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 203557
Tradename: | PIPERACILLIN AND TAZOBACTAM |
Applicant: | Sandoz |
Ingredient: | piperacillin sodium; tazobactam sodium |
Patents: | 0 |
Pharmacology for NDA: 203557
Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 203557
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 203557 | ANDA | Hospira, Inc | 0409-2999 | 0409-2999-14 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (0409-2999-14) / 60 mL in 1 VIAL, PHARMACY BULK PACKAGE |
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 203557 | ANDA | Sandoz Inc | 0781-3180 | 0781-3180-94 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (0781-3180-94) / 250 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | ||||
Approval Date: | Oct 29, 2014 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | ||||
Approval Date: | Jul 8, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription